Altmann, Daniel M. http://orcid.org/0000-0002-2436-6192
Reynolds, Catherine J.
Joy, George
Otter, Ashley D. http://orcid.org/0000-0002-8317-9194
Gibbons, Joseph M. http://orcid.org/0000-0002-7238-2381
Pade, Corinna
Swadling, Leo http://orcid.org/0000-0002-0537-6715
Maini, Mala K. http://orcid.org/0000-0001-6384-1462
Brooks, Tim http://orcid.org/0000-0002-3783-1284
Semper, Amanda
McKnight, Áine
Noursadeghi, Mahdad http://orcid.org/0000-0002-4774-0853
Manisty, Charlotte http://orcid.org/0000-0003-0245-7090
Treibel, Thomas A.
Moon, James C.
Boyton, Rosemary J. http://orcid.org/0000-0002-5608-0797
,
Funding for this research was provided by:
RCUK | Medical Research Council (MR/W020610/1, MR/W020610/1, MR/W020610/1, MR/W020610/1, MR/W020610/1)
Article History
Received: 30 November 2022
Accepted: 27 July 2023
First Online: 23 August 2023
Competing interests
: R.J.B. and D.M.A. are members of the Global T cell Expert Consortium and have consulted for Oxford Immunotec outside the submitted work. DMA has received honorarium payments from Pfizer, AstraZeneca and Novavax for consultancy work. The remaining authors declare no competing interests.